OMOlivier Morin

Olivier Morin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olivier Morin has a total of 254 co-authors. Here are the top co-authors by number of shared publications:

  • Gilmer Valdes

    Department of Radiation Oncology, University of California San Francisco, San Francisco, USA

    5 shared publications
  • Shannon E. Fogh

    Department of Radiation Oncology, University of California San Francisco, San Francisco, USA

    5 shared publications
  • Javier E. Villanueva-Meyer

    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, USA

    4 shared publications
  • Martin Vallières

    Medical Physics Unit, Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada

    4 shared publications
  • Penny K. Sneed

    Department of Radiation Oncology, University of California San Francisco, San Francisco, USA

    4 shared publications
  • Philippe Lambin

    The D-Lab, Department of Precision Medicine, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands

    4 shared publications

Latest Publications

  • Open Access

    Integrated isocenter and sector duration optimization (ISDO) for gamma knife radiosurgery

    by Jingjie Yu, Dante P I Capaldi, Olivier Morin, Ke Sheng, Qihui Lyu

    Objective. Current Gamma Knife (GK) treatment planning algorithms typically determine isocenter locations using geometric heuristics rather than dose-driven optimization. Isocenters are either placed automatically (using center-of-mass, skeleton-based, or curvature-based algorithms) or manually by planners, followed by a separate sector duration optimization (SDO) with fixed isocenter locations. Since the isocenter selection is separate from the dosimetry optimization, the SDO step is often constrained by a suboptimal isocenter configuration, limiting achievable plan quality and leading to unnecessarily long beam-on time (BOT). Approach. We introduce an integrated isocenter and SDO framework (ISDO) that replaces heuristic isocenter placement with a dose-driven joint ISDO. The framework includes a group-sparsity regularization for isocenter selection and an explicit BOT regularization for delivery efficiency. The selected isocenters are further refined through an SDO module, followed by a post-processing stage that converts the optimized sector–collimator patterns into deliverable shot configuration. The framework was evaluated using 12 GK cases spanning a variety of clinical indications, including arteriovenous malformation, vestibular schwannoma, meningioma, and pituitary adenoma. Main Results. With similar or better plan quality, ISDO plans used fewer or equal shots and substantially reduced the BOT. Across all cases, ISDO reduced the number of shots by 15.06% and BOT by 20.77%. With similar target coverage, the selectivity and Paddick conformity index increased by 5.77% and 5.82%, and R 50 and D 2 cm decreased by 6.45% and 5.23%. The maximum and mean doses of organs-at-risk were also reduced by 16.0% and 28.8% respectively. Significance. By incorporating isocenter selection directly into the BOT-aware inverse-planning framework and driving the isocenter selection through a group sparsity term, the proposed ISDO method achieved more efficient and conformal GK plans than current clinical GK treatment planning approaches.

  • Open Access

    Cerebral vasculature shapes the spatial patterning of brain metastases

    by Asa Farahani, Zhen-Qi Liu, Vincent Bazinet, Charles P. Couturier, Evan Porter, Dante P. I. Capaldi, Olivier Morin, Alain Dagher, Bratislav Misic

    Primary cancer cells that originate in diverse tissues in the body can spread to the brain through various physiological pathways and form metastatic tumors. The spatial patterning of brain metastases is highly stereotyped across individuals, but the physiological factors that confer regional vulnerability to tumor colonization are poorly understood. Here we map the brain metastases associated with primary breast cancer, lung cancer, and malignant melanoma to the multiscale organization of the brain. We analyze structural magnetic resonance imaging (MRI) data from more than 2,300 cancer patients with approximately 10,000 brain metastases to estimate metastatic frequency maps. We then examine whether transcriptional (microarray profiling), functional (functional MRI), and vascular (arterial spin labeling) features can predict the spatial pattern of each brain metastasis type. Our analyses highlight vascular anatomy as an integral determinant of metastatic patterning, particularly in breast and lung cancers. We find arterial border-zones as sites of elevated vulnerability to metastatic invasion. These areas, characterized by slow flow and small-caliber vessels, create a hemodynamic environment that favors the arrest and extravasation of circulating tumor cells. Together, these results provide quantitative support for the long-standing hypothesis that vascular architecture and its biomechanical properties constrain metastatic seeding in the brain. Identifying vascular topology as a key determinant of metastatic patterning suggests that systemic vascular and metabolic factors may contribute to metastatic risk.

  • Top Cited Papers
    Open Access

    Large language model trained on clinical oncology data predicts cancer progression

    by Menglei Zhu, Hui Lin, Jue Jiang, Abbas J. Jinia, Justin Jee, Karl Pichotta, Michele Waters, Doori Rose, Nikolaus Schultz, Sulov Chalise, et al.

    Subspecialty knowledge barriers have limited the adoption of large language models (LLMs) in oncology. We introduce Woollie, an open-source, oncology-specific LLM trained on real-world data from Memorial Sloan Kettering Cancer Center (MSK) across lung, breast, prostate, pancreatic, and colorectal cancers, with external validation using University of California, San Francisco (UCSF) data. Woollie surpasses ChatGPT in medical benchmarks and excels in eight non-medical benchmarks. Analyzing 39,319 radiology impression notes from 4002 patients, it achieved an overall area under the receiver operating characteristic curve (AUROC) of 0.97 for cancer progression prediction on MSK data, including a notable 0.98 AUROC for pancreatic cancer. On UCSF data, it achieved an overall AUROC of 0.88, excelling in lung cancer detection with an AUROC of 0.95. As the first oncology specific LLM validated across institutions, Woollie demonstrates high accuracy and consistency across cancer types, underscoring its potential to enhance cancer progression analysis.


  • Open Access

    Author Correction: Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy

    by Jorge Barrios, Evan Porter, Dante P. I. Capaldi, Taman Upadhaya, William C. Chen, Julian R. Perks, Aditya Apte, Michalis Aristophanous, Eve LoCastro, Dylan Hsu, et al.

  • Open Access

    Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy

    by Jorge Barrios, Evan Porter, Dante P. I. Capaldi, Taman Upadhaya, William C. Chen, Julian R. Perks, Aditya Apte, Michalis Aristophanous, Eve LoCastro, Dylan Hsu, et al.

    Brain metastases are a frequent and debilitating manifestation of advanced cancer. Here, we collect and analyze neuroimaging of 3,065 cancer patients with 13,067 brain metastases, representing an extensive collection for research. We find that metastases predominantly localize to high perfusion areas near the grey-white matter junction, but also identify notable differences depending on the primary cancer histology as well as brain regions which do not conform to this relationship. Lung and breast cancers, in contrast to melanoma, frequently metastasize to the cerebellum, hinting at biological pathways of spread. Additionally, the deep brain structures are relatively spared from metastasis, regardless of primary cancer type. Leveraging this data, we propose a probabilistic brain metastasis risk model to enhance the therapeutic ratio of whole-brain radiotherapy by targeting high risk areas while preserving cortical and subcortical brain regions of functional significance and low metastasis risk, potentially reducing the cognitive side effects of therapy.


  • Top Cited Papers

    The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights

    by Philip Whybra, Alex Zwanenburg, Vincent Andrearczyk, Roger Schaer, Aditya P. Apte, Alexandre Ayotte, Bhakti Baheti, Spyridon Bakas, Andrea Bettinelli, Ronald Boellaard, et al.

    Filters are commonly used to enhance specific structures and patterns in images, such as vessels or peritumoral regions, to enable clinical insights beyond the visible image using radiomics. However, their lack of standardization restricts reproducibility and clinical translation of radiomics decision support tools. In this special report, teams of researchers who developed radiomics software participated in a three-phase study (September 2020 to December 2022) to establish a standardized set of filters. The first two phases focused on finding reference filtered images and reference feature values for commonly used convolutional filters: mean, Laplacian of Gaussian, Laws and Gabor kernels, separable and nonseparable wavelets (including decomposed forms), and Riesz transformations. In the first phase, 15 teams used digital phantoms to establish 33 reference filtered images of 36 filter configurations. In phase 2, 11 teams used a chest CT image to derive reference values for 323 of 396 features computed from filtered images using 22 filter and image processing configurations. Reference filtered images and feature values for Riesz transformations were not established. Reproducibility of standardized convolutional filters was validated on a public data set of multimodal imaging (CT, fluorodeoxyglucose PET, and T1-weighted MRI) in 51 patients with soft-tissue sarcoma. At validation, reproducibility of 486 features computed from filtered images using nine configurations × three imaging modalities was assessed using the lower bounds of 95% CIs of intraclass correlation coefficients. Out of 486 features, 458 were found to be reproducible across nine teams with lower bounds of 95% CIs of intraclass correlation coefficients greater than 0.75. In conclusion, eight filter types were standardized with reference filtered images and reference feature values for verifying and calibrating radiomics software packages. A web-based tool is available for compliance checking.


  • Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence–Ready Informatics Ecosystem for Radiation Oncology

    by Danielle S. Bitterman, Michael F. Gensheimer, David Jaffray, Daniel A. Pryma, Steve B. Jiang, Olivier Morin, Jorge Barrios Ginart, Taman Upadhaya, Katherine A. Vallis, John M. Buatti, et al.

    In August 2022, the Cancer Informatics for Cancer Centers brought together cancer informatics leaders for its biannual symposium, Precision Medicine Applications in Radiation Oncology, co-chaired by Quynh-Thu Le, MD (Stanford University), and Walter J. Curran, MD (GenesisCare). Over the course of 3 days, presenters discussed a range of topics relevant to radiation oncology and the cancer informatics community more broadly, including biomarker development, decision support algorithms, novel imaging tools, theranostics, and artificial intelligence (AI) for the radiotherapy workflow. Since the symposium, there has been an impressive shift in the promise and potential for integration of AI in clinical care, accelerated in large part by major advances in generative AI. AI is now poised more than ever to revolutionize cancer care. Radiation oncology is a field that uses and generates a large amount of digital data and is therefore likely to be one of the first fields to be transformed by AI. As experts in the collection, management, and analysis of these data, the informatics community will take a leading role in ensuring that radiation oncology is prepared to take full advantage of these technological advances. In this report, we provide highlights from the symposium, which took place in Santa Barbara, California, from August 29 to 31, 2022. We discuss lessons learned from the symposium for data acquisition, management, representation, and sharing, and put these themes into context to prepare radiation oncology for the successful and safe integration of AI and informatics technologies.


  • Open Access

    Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics

    by Simon A. Keek, Manon Beuque, Sergey Primakov, Henry C. Woodruff, Avishek Chatterjee, Janita E. van Timmeren, Martin Vallières, Lizza E. L. Hendriks, Johannes Kraft, Nicolaus Andratschke, et al.

    Introduction: There is a cumulative risk of 20–40% of developing brain metastases (BM) in solid cancers. Stereotactic radiotherapy (SRT) enables the application of high focal doses of radiation to a volume and is often used for BM treatment. However, SRT can cause adverse radiation effects (ARE), such as radiation necrosis, which sometimes cause irreversible damage to the brain. It is therefore of clinical interest to identify patients at a high risk of developing ARE. We hypothesized that models trained with radiomics features, deep learning (DL) features, and patient characteristics or their combination can predict ARE risk in patients with BM before SRT.Methods: Gadolinium-enhanced T1-weighted MRIs and characteristics from patients treated with SRT for BM were collected for a training and testing cohort (N = 1,404) and a validation cohort (N = 237) from a separate institute. From each lesion in the training set, radiomics features were extracted and used to train an extreme gradient boosting (XGBoost) model. A DL model was trained on the same cohort to make a separate prediction and to extract the last layer of features. Different models using XGBoost were built using only radiomics features, DL features, and patient characteristics or a combination of them. Evaluation was performed using the area under the curve (AUC) of the receiver operating characteristic curve on the external dataset. Predictions for individual lesions and per patient developing ARE were investigated.Results: The best-performing XGBoost model on a lesion level was trained on a combination of radiomics features and DL features (AUC of 0.71 and recall of 0.80). On a patient level, a combination of radiomics features, DL features, and patient characteristics obtained the best performance (AUC of 0.72 and recall of 0.84). The DL model achieved an AUC of 0.64 and recall of 0.85 per lesion and an AUC of 0.70 and recall of 0.60 per patient.Conclusion: Machine learning models built on radiomics features and DL features extracted from BM combined with patient characteristics show potential to predict ARE at the patient and lesion levels. These models could be used in clinical decision making, informing patients on their risk of ARE and allowing physicians to opt for different therapies.


  • Top Cited Papers
    Open Access

    Automated detection and segmentation of non-small cell lung cancer computed tomography images

    by Sergey P. Primakov, Abdalla Ibrahim, Janita E. van Timmeren, Guangyao Wu, Simon A. Keek, Manon Beuque, Renée W. Y. Granzier, Elizaveta Lavrova, Madeleine Scrivener, Sebastian Sanduleanu, et al.

    Detection and segmentation of abnormalities on medical images is highly important for patient management including diagnosis, radiotherapy, response evaluation, as well as for quantitative image research. We present a fully automated pipeline for the detection and volumetric segmentation of non-small cell lung cancer (NSCLC) developed and validated on 1328 thoracic CT scans from 8 institutions. Along with quantitative performance detailed by image slice thickness, tumor size, image interpretation difficulty, and tumor location, we report an in-silico prospective clinical trial, where we show that the proposed method is faster and more reproducible compared to the experts. Moreover, we demonstrate that on average, radiologists & radiation oncologists preferred automatic segmentations in 56% of the cases. Additionally, we evaluate the prognostic power of the automatic contours by applying RECIST criteria and measuring the tumor volumes. Segmentations by our method stratified patients into low and high survival groups with higher significance compared to those methods based on manual contours.


  • An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication

    by Olivier Morin, Martin Vallières, Steve Braunstein, Jorge Barrios Ginart, Taman Upadhaya, Henry C. Woodruff, Alex Zwanenburg, Avishek Chatterjee, Javier E. Villanueva-Meyer, Gilmer Valdes, et al.

    Despite widespread adoption of electronic health records (EHRs), most hospitals are not ready to implement data science research in the clinical pipelines. Here, we develop MEDomics, a continuously learning infrastructure through which multimodal health data are systematically organized and data quality is assessed with the goal of applying artificial intelligence for individual prognosis. Using this framework, currently composed of thousands of individuals with cancer and millions of data points over a decade of data recording, we demonstrate prognostic utility of this framework in oncology. As proof of concept, we report an analysis using this infrastructure, which identified the Framingham risk score to be robustly associated with mortality among individuals with early-stage and advanced-stage cancer, a potentially actionable finding from a real-world cohort of individuals with cancer. Finally, we show how natural language processing (NLP) of medical notes could be used to continuously update estimates of prognosis as a given individual’s disease course unfolds.